Snezana Milosavljevic

This study shows that maternal sleep fragmentation and inflammation increase fetal brain kynurenic acid, linking sleep disruption to neurodevelopmental risks.

This study investigates how time of day affects kynurenic acid (KYNA) synthesis and inhibition in rats, showing phase-dependent changes in KYNA levels and KAT II enzyme activity.

This study shows that parental Kmo genotype affects offspring behavior and sleep in sex-specific ways through changes in the kynurenine pathway and brain mitochondrial function.

This paper investigates the impact of the PDE11A-Y727C variant on neural physiology, showing reduced catalytic activity and altered subcellular compartmentalization without significant effects on eye growth or sleep quality.

The paper investigates how inhibiting kynurenine aminotransferase II (KAT II) affects sleep disturbances caused by kynurenine in rats.

This study shows that inhibiting KAT II reduces KYNA levels, improving sleep quality in rats exposed to embryonic kynurenine and in controls.